OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials
Dario Giugliano, Miriam Longo, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice (2020) Vol. 162, pp. 108114-108114
Closed Access | Times Cited: 48
Dario Giugliano, Miriam Longo, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice (2020) Vol. 162, pp. 108114-108114
Closed Access | Times Cited: 48
Showing 26-50 of 48 citing articles:
Low glycaemic state increases risk of frailty and functional decline in older people with type 2 diabetes mellitus – Evidence from a systematic review
Ahmed H. Abdelhafiz, Sanne A. E. Peters, Alan J. Sinclair
Diabetes Research and Clinical Practice (2021) Vol. 181, pp. 109085-109085
Closed Access | Times Cited: 13
Ahmed H. Abdelhafiz, Sanne A. E. Peters, Alan J. Sinclair
Diabetes Research and Clinical Practice (2021) Vol. 181, pp. 109085-109085
Closed Access | Times Cited: 13
Management of type 2 diabetes in patients with frailty
Kara Hawker, Ripa Akter, Frank Molnar, et al.
Canadian Family Physician (2024) Vol. 70, Iss. 1, pp. 30-32
Open Access | Times Cited: 1
Kara Hawker, Ripa Akter, Frank Molnar, et al.
Canadian Family Physician (2024) Vol. 70, Iss. 1, pp. 30-32
Open Access | Times Cited: 1
Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review
Pann Ei Hnynn, S. Parker, Dima Abdelhafiz, et al.
Diabetes Research and Clinical Practice (2024) Vol. 211, pp. 111662-111662
Closed Access | Times Cited: 1
Pann Ei Hnynn, S. Parker, Dima Abdelhafiz, et al.
Diabetes Research and Clinical Practice (2024) Vol. 211, pp. 111662-111662
Closed Access | Times Cited: 1
Interventions for primary prevention of cardiovascular disease: umbrella review of systematic reviews
Olalekan A. Uthman, Lena Al-Khudairy, Chidozie Nduka, et al.
Health Technology Assessment (2024), pp. 1-26
Open Access | Times Cited: 1
Olalekan A. Uthman, Lena Al-Khudairy, Chidozie Nduka, et al.
Health Technology Assessment (2024), pp. 1-26
Open Access | Times Cited: 1
Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors
Viktor Rotbain Curovic, Elisabeth B. Stougaard, Tine W. Hansen
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S6, pp. 22-32
Closed Access | Times Cited: 1
Viktor Rotbain Curovic, Elisabeth B. Stougaard, Tine W. Hansen
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S6, pp. 22-32
Closed Access | Times Cited: 1
Sodium-Glucose Cotransporter-2 Inhibitors and Protection Against stroke in Patients with type 2 Diabetes and Impaired Renal Function: A Systematic Review and Meta-Analysis
Fotios Barkas, Sempastian Filippas-Ntekouan, Evangelos Liberopoulos, et al.
Journal of Stroke and Cerebrovascular Diseases (2021) Vol. 30, Iss. 5, pp. 105708-105708
Closed Access | Times Cited: 9
Fotios Barkas, Sempastian Filippas-Ntekouan, Evangelos Liberopoulos, et al.
Journal of Stroke and Cerebrovascular Diseases (2021) Vol. 30, Iss. 5, pp. 105708-105708
Closed Access | Times Cited: 9
Overtreatment and undertreatment in a sample of elderly people with diabetes
Labib AL‐Musawe, Carla Torre, José Guerreiro, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 7
Labib AL‐Musawe, Carla Torre, José Guerreiro, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 7
New hypoglycaemic therapy in frail older people with diabetes mellitus-phenotypic status likely to be more important than functional status
Ahmed H. Abdelhafiz, Demelza Emmerton, Alan J. Sinclair
Diabetes Research and Clinical Practice (2020) Vol. 169, pp. 108438-108438
Closed Access | Times Cited: 5
Ahmed H. Abdelhafiz, Demelza Emmerton, Alan J. Sinclair
Diabetes Research and Clinical Practice (2020) Vol. 169, pp. 108438-108438
Closed Access | Times Cited: 5
Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people
Demelza Emmerton, Ahmed H. Abdelhafiz
Hospital Practice (2021) Vol. 49, Iss. 3, pp. 164-175
Closed Access | Times Cited: 5
Demelza Emmerton, Ahmed H. Abdelhafiz
Hospital Practice (2021) Vol. 49, Iss. 3, pp. 164-175
Closed Access | Times Cited: 5
Prise en charge du diabète de type 2 chez les patients fragiles
Kara Hawker, Ripa Akter, Frank Molnar, et al.
Canadian Family Physician (2024) Vol. 70, Iss. 1, pp. e10-e13
Open Access
Kara Hawker, Ripa Akter, Frank Molnar, et al.
Canadian Family Physician (2024) Vol. 70, Iss. 1, pp. e10-e13
Open Access
Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: systematic review and meta-analysis
Anika Bilal, Fanchao Yi, Gonzalo Romero Gonzalez, et al.
Research Square (Research Square) (2024)
Open Access
Anika Bilal, Fanchao Yi, Gonzalo Romero Gonzalez, et al.
Research Square (Research Square) (2024)
Open Access
The benefits and risks of new antidiabetic drugs for the treatment of geriatric patients with diabetes
Darina Matvejeva, Martina Nováková, Pavlína Piťhová, et al.
Vnitřní lékařství (2024) Vol. 70, Iss. 7, pp. 430-437
Open Access
Darina Matvejeva, Martina Nováková, Pavlína Piťhová, et al.
Vnitřní lékařství (2024) Vol. 70, Iss. 7, pp. 430-437
Open Access
SGLT2 Inhibitors and Mechanism of Cardiovascular Benefits in Type 2 Diabetes
Mukesh Nandave
(2024), pp. 33-149
Closed Access
Mukesh Nandave
(2024), pp. 33-149
Closed Access
Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis
Lili Jiang, Yanyan Jia, Xiaoyu Wang, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 5, pp. 407-416
Closed Access | Times Cited: 1
Lili Jiang, Yanyan Jia, Xiaoyu Wang, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 5, pp. 407-416
Closed Access | Times Cited: 1
Level of glycemic control among US type 2 diabetes mellitus patients on dual therapy of metformin and sodium–glucose cotransporter 2 inhibitor: a retrospective database study
Dominik Lautsch, Kristy Iglay, Lingfeng Yang, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 10, pp. 1583-1589
Open Access | Times Cited: 2
Dominik Lautsch, Kristy Iglay, Lingfeng Yang, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 10, pp. 1583-1589
Open Access | Times Cited: 2
Safety of SGLT2 inhibitors in very elderly diabetic type 2 patients in real life
Ramón Baeza‐Trinidad, José Daniel Mosquera-Lozano
Iberoamerican Journal of Medicine (2023) Vol. 5, Iss. 3, pp. 118-122
Open Access
Ramón Baeza‐Trinidad, José Daniel Mosquera-Lozano
Iberoamerican Journal of Medicine (2023) Vol. 5, Iss. 3, pp. 118-122
Open Access
Guía mexicana de práctica clínica para el diagnóstico y tratamiento en pacientes adultos con diabetes tipo 2
Nikos Christo Secchi Nicolás, Fernando J. Lavalle‐González, Juan C. Garnica-Cuéllar, et al.
Revista Mexicana de Endocrinología Metabolismo y Nutrición (2023) Vol. 10, Iss. 92
Open Access
Nikos Christo Secchi Nicolás, Fernando J. Lavalle‐González, Juan C. Garnica-Cuéllar, et al.
Revista Mexicana de Endocrinología Metabolismo y Nutrición (2023) Vol. 10, Iss. 92
Open Access
Recomendaciones en el manejo de la hiperglucemia en pacientes con diabetes mellitus según grado de fragilidad
Laura Romera Liébana
Diabetes práctica (2023) Vol. 14, Iss. 3
Open Access
Laura Romera Liébana
Diabetes práctica (2023) Vol. 14, Iss. 3
Open Access
Choix entre une gliptine et une gliflozine chez le patient âgé avec un diabète de type 2
André Scheen
Médecine des Maladies Métaboliques (2022) Vol. 16, Iss. 3, pp. 264-270
Closed Access
André Scheen
Médecine des Maladies Métaboliques (2022) Vol. 16, Iss. 3, pp. 264-270
Closed Access
SGLT2-inhibithors in frail older people with type 2 diabetes
Andrea Da Porto
The Journal of AMD (2022) Vol. 25, Iss. 3, pp. 164-164
Open Access
Andrea Da Porto
The Journal of AMD (2022) Vol. 25, Iss. 3, pp. 164-164
Open Access
Drug Utilization Evaluation of Antidiabetic Agents in Primary Care Clinics of a South Indian Rural Province
Kumutha Theivasigamani, Senthilkumar Palaniappan
International Journal Of Pharmaceutical Research And Allied Sciences (2022) Vol. 11, Iss. 4, pp. 1-13
Open Access
Kumutha Theivasigamani, Senthilkumar Palaniappan
International Journal Of Pharmaceutical Research And Allied Sciences (2022) Vol. 11, Iss. 4, pp. 1-13
Open Access
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective study
Miriam Longo, Lorenzo Scappaticcio, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108990-108990
Closed Access
Miriam Longo, Lorenzo Scappaticcio, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108990-108990
Closed Access
